Artemisone inhibits in vitro and in vivo propagation of Babesia bovis and B. bigemina parasites

Experimental Parasitology

Volumn 135, Issue 4, 2013, Pages 690-694

  Mazuz, Monica L ^a   Golenser, Jacob ^b,c   Fish, Leah ^a   Haynes, Richard K ^d   Wollkomirsky, Ricardo ^a   Leibovich, Benjamin ^a   Shkap, Varda ^a  

^a KIMRON VETERINARY INSTITUTE   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c UNIVERSITY OF SYDNEY   (Australia)

^d NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Artemisinin; Artemisone; Babesia bigemina; Babesia bovis; Bovine babesiosis; Treatment

Indexed keywords

ARTEMISONE; DIMINAZENE ACETURATE;

ABDOMINAL PAIN; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; BABESIA BIGEMINA; BABESIA BOVIS; BLOOD PARASITE; CALF (BOVINE); CONCENTRATION RESPONSE; DRUG SCREENING; DRUG STRUCTURE; DRUG TOLERABILITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARASITE IMMUNITY; PARASITEMIA; PIROPLASMOSIS; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ARTEMISININ; ARTEMISONE; BABESIA BIGEMINA; BABESIA BOVIS; BOVINE BABESIOSIS; TREATMENT;

ANIMALS; ANTIPROTOZOAL AGENTS; ARTEMISININS; BABESIA; BABESIA BOVIS; BABESIOSIS; CATTLE; CATTLE DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; INHIBITORY CONCENTRATION 50; PARASITEMIA; RANDOM ALLOCATION;

EID: 84887541577     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2013.10.006     Document Type: Article

References (26)

1. Bock R.E., Jackson L., de Vos A.J., Jorgensen W. Babesiosis of cattle. Parasitology 2004, 129(Suppl.):S247-S269.
2. Brown W.C., Palmer G.H. Designing blood-stage vaccines against Babesia bovis and B. bigemina. Parasitol. Today 1999, 15:275-281.
3. Callow L.L. Sterile immunity, co-infectious immunity and strain differences in Babesia bigemina infections. Parasitology 1967, 57:455-465.
4. Callow L.L. A note on homologous strain immunity in Babesia argentina infections. Aust. Vet. J. 1968, 44:268-269.
5. D'Alessandro S., Gelatib M., Basilicoa N., Paratib E.A., Haynes R.K., Taramellia D. Differential effects on angiogenesis of two antimalarial compounds, dihydroartemisinin and artemisone: implications for embryotoxicity. Toxicology 2007, 241:66-74.
6. De Vos A.J., Dalgliesh R.J., McGregor W. Effect of imidocarb dipropionate prophylaxis on the infectivity and immunogenicity of a Babesia bovis vaccine in cattle. Aust. Vet. J. 1986, 63:174-178.
7. De Waal D., Combrink M. Live vaccines against bovine babesiosis. Vet. Parasitol. 2006, 138:88-96.
8. Dunay I.R., Chan W.C., Haynes R.K., Sibley L.D. Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model. Antimicrob. Agents Chemother. 2009, 53:4450-4456.
9. Fish L., Leibovich B., Krigel Y., McElwain T., Shkap V. Vaccination of cattle against B. bovis infection with live attenuated parasites and non-viable immunogens. Vaccine 2008, 26(S6):G29-G33.
10. Goo Y.K., Terkawi M.A., Jia H., Aboge G.O., Ooka H., Nelson B., Kim S., Sunaga F., Namikawa K., Igarashi I., Nishikawa Y., Xuan X. Artesunate, a potential drug for treatment of Babesia infection. Parasitol. Int. 2010, 59:481-486.
11. Haynes R.K., Fugmann B., Stetter J., Rieckmann K., Heilmann H.D., Chan H.W., Cheung M.K., Lam W.L., Wong H.N., Croft S.L., Vivas L., Rattray L., Stewart L., Peters W., Robinson B.L., Edstein M.D., Kotecka B., Kyle D.E., Beckermann B., Gerisch M., Radtke M., Schmuck G., Steinke W., Wollborn U., Schmeer K., Römer A. Artemisone a highly active antimalarial drug of the artemisinin class. Angew. Chem. Int. Ed. Engl. 2006, 45:2082-2088.
12. Krishna S., Gottfried Kremsner P. Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy. Trends Parasitol. 2013, 29:313-317.
13. Kumar S., Gupta A.K., Pal Y., Dwivedi S.K. In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys. J. Vet. Med. Sci. 2003, 65:1171-1177.
14. Levy M.G., Ristic M. Babesia bovis: continuous cultivation in a microaerophilous stationary phase culture. Science 1980, 207:1218-1220.
15. Löhr K.F. Immunity to Babesia bigemina in experimentally infected cattle. J. Protozool. 1972, 19:658-660.
16. Matsuu A., Yamasaki M., Xuan X., Ikadai H., Hikasa Y. In vitro evaluation of the growth inhibitory activities of 15 drugs againstBabesia gibsoni (Aomori strain). Vet. Parasitol. 2008, 157:1-8.
17. Mazuz L.M., Haynes R., Shkap V., Fish L., Wollkomirsky R., Leibovich B., Molad T., Savitsky I., Golenser J. Neospora caninum: in vivo and in vitro treatment with artemisone. Vet. Parasitol. 2011, 187:99-104.
18. Meyer, P.J., 2002. Enhancement of the action of anti-infective agents. S. African patent no WO 02/05850 A2.
19. Mosqueda J., Olvera-Ramirez A., Aguilar-Tipacamu G., Canto G.J. Current advances in detection and treatment of babesiosis. Curr. Med. Chem. 2012, 19:1504-1518.
20. Nagai A., Yokoyama N., Matsuo T., Bork S., Hirata H., Xuan X., Zhu Y., Claveria F.G., Fujisaki K., Igarashi I. Growth-inhibitory effects of artesunate, pyrimethamine, and pamaquine against Babesia equi and Babesia caballi in in vitro cultures. Antimicrob. Agents Chemother. 2003, 47:800-803.
21. Nagelschmitz J., Voith B., Wensing G., Roemer A., Fugmann B., Haynes R.K., Kotecka B.M., Rieckmann K.H., Edstein M.D. First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone. Antimicrob. Agents Chemother. 2008, 52:3085-3091.
22. Sibley C.H., Barnes K.I., Watkins W.M., Plowe C.V. A network to monitor antimalarial drug resistance: a plan for moving forward. Trends Parasitol. 2008, 24:43-48.
23. Steyn J.D., Wiesner L.,Plessis L.H., Grobler A.F., Smith P.J., Chan W.C., Haynes R.K., Kotzé A.F. Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of pheroid technology. Int. J. Pharmacol. 2011, 414:260-266.
24. Suarez E.C., Noh S. Emerging perspectives in the research of bovine babesiosis and anaplasmosis. Vet. Parasitol. 2011, 180:109-125.
25. Vial H.J., Gorenflot A. Chemotherapy against babesiosis. Vet. Parasitol. 2006, 138:147-160.
26. Waknine-Grinberg J.H., Hunt N., Bentura-Marciano A., McQuillan J.A., Chan H.W., Chan W.C., Barenholz Y., Haynes R.K., Golenser J. Artemisone effective against murine cerebral malaria. Malar. J. 2010, 9:227. 10.1186/1475-2875-9-227.